sur Research Dynamics
CPH Group Navigates Mixed Markets Amid Strategic Expansion
CPH Group reported a slight decrease in net sales for the first half of 2025, at CHF 176.0 million, down 0.5% year-on-year. The group's EBITDA remained stable at CHF 30.2 million, maintaining a margin of 17.2%. Challenges included currency headwinds and higher costs following a division spin-off. EBIT saw a decline of 6.8% to CHF 21.9 million, affected by acquisition-related depreciation. The net result was CHF 17.1 million, a drop attributed to prior-year one-off gains and increased acquisition financial costs.
Zeochem's net sales fell 7.2% due to lower demand and FX effects, despite strong performance in high-value molecular sieves. Perlen Packaging saw a 3.1% sales increase with improving order volumes and stable PVC prices. Looking ahead, CPH foresees potential growth in the second half, contingent on overcoming existing economic challenges.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Research Dynamics